top of page

Who will benefit from the more accurate measurement of RBC deformability and CSS?

Writer's picture: RheoMeditech Inc.RheoMeditech Inc.

Ultimately, anyone at risk of developing circulatory disorders will benefit from better technology for measuring cell deformability and critical shear stress. Quick and easy measurements at the point of care will provide earlier detection of the circulatory diseases including diabetic kidney disease and diabetic retinopathy , allowing patients to be treated on time and to have healthy life.

19 views0 comments

Recent Posts

See All

Does RheoScan receive any approval ?

RheoScan received approval from Korea Food & Drug Administration(KFDA) though GMP tests as a First class medical device in Dec., 2005....

Comentarios


rheo word only.png

(주)리오메디텍 

서울특별시 동대문구 무학로45길 44, 2층 

사업자등록번호: 504-81-53750  

RheoMeditech Inc.

2F 44 Muhakro-45-gil,

Seoul, South Korea

​Tel: +82-2-537-5111 

Copyright 2024 © RheoMeditech Inc. All Rights Reserved

bottom of page